Alk-Abello jumps after Q2 beat on strong tablet sales in Japan

Alk-Abello A/S

24/08/2023 08:25

** Shares in Alk-Abello  ALKb.CO  rise 7% after the Danish
provider of allergy treatment products posted Q2 operating
profit almost doubling year on year, amid strong tablet sales in
Japan, cost efficiencies
    ** The company reports quarterly EBIT at 97 million Danish
crowns ($14 million) against 48 million crowns a year ago and
37% above 71 million crowns expected by Jefferies
    ** It says revenue in international markets rose by 64%,
mainly due to shipments of allergy immunotherapy tablets to
Japan, as the country launched a plan to further combat
respiratory allergy
    ** "EBIT  beat  helped  by  a  better  than  expected  gross
 margin  with production efficiencies offsetting larger tablet
shipments to Torii at lower margins", Jefferies says
    ** Alk-Abello shares sit on top of STOXX 600  .STOXX 

($1 = 6.8648 Danish crowns)

 (Reporting by Boleslaw Lasocki)
 ((boleslaw.lasocki@thomsonreuters.com))